Tauns announced a capital and business alliance with Taiwanese company AsiaPathogenomics, with the aim of jointly developing an infectious disease metagenomic next-generation sequencing business in Japan and expanding testing capabilities at clinical laboratory centers.
After trading ended on the 20th, Tauns announced a capital and business alliance with Taiwan-based infectious disease testing services company AsiaPathogenomics. The companies said they had reached an agreement in principle to jointly develop an infectious disease metagenomic next-generation sequencing business in Japan.
Tauns also stated that it plans to expand testing capabilities at its clinical laboratory centers, with the alliance expected to strengthen its testing capacity.
This report is based on information from Minkabu Press, with news.livedoor.com cited as the supporting source.